Skip to main content
Signal8

Cryoport, Inc. (CYRX)

Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.

Sector: Pharmaceutical Preparations

Industry: Integrated Freight & Logistics

Cryoport, Inc. logo

Cryoport, Inc.

NASDAQ:CYRXIndustrials
+0.84%$17.98
AH Close$17.98+0.00%vs close
Mkt Cap$910.67M
Float48.21M
O/S50.65M
Inst Own88.6%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$910.67M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership88.64%

based on 50.65M shares outstanding

SectorIndustrials
IndustryIntegrated Freight & Logistics
ExchangeNASDAQ
CountryUSUS
IPO DateAug 22, 2005
Shares Outstanding50.65M
Float48.21M
Company Overview

Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials.

Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering.

The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.

Leadership

Dr. Hariri

Member of the Nomination and Governance Committee; Chair of the Science and Technology Committee

Edward Zecchini

Senior Vice President and Chief Digital & Technology Officer

Jerrell W. Shelton

Chairman, President & Chief Executive Officer

Mark Sawicki, Ph.D.

Senior Vice President and Chief Scientific Officer, also CEO of Cryoport Systems, LLC

Employees

688

Country

US

Sector

Industrials

Website

cryoportinc.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$19.00+5.7%
Low $16High $21
Ratings Distribution
BUY
15
HOLD
4
SELL
0
TOTAL19
Insider Trading
InsiderTypeShares
SHELTON JERRELL profile photoSHELTON JERRELLSale28.8K
ZECCHINI EDWARD J profile photoZECCHINI EDWARD JOption Exercise33.6K
ZECCHINI EDWARD J profile photoZECCHINI EDWARD JOption Exercise33.6K
ZECCHINI EDWARD J profile photoZECCHINI EDWARD JSale33.6K
ZECCHINI EDWARD J profile photoZECCHINI EDWARD JOption Exercise1.4K
ZECCHINI EDWARD J profile photoZECCHINI EDWARD JSale1.4K
Shareholders
88.6%
Institutional
(187)
3.5%
Insiderⓘ
(8)
0.0%
5%+ Owners
(0)
7.8%
Unattributed (incl. retail)ⓘ
Institutional88.6%
Insider3.5%
Unattributed (incl. retail)7.8%
Top Shareholders
NameShares%
BlackRock, Inc. logo
BlackRock, Inc.
4.2M8.3%
CADIAN CAPITAL MANAGEMENT, LP logo
CADIAN CAPITAL MANAGEMENT, LP
2.9M5.8%
MORGAN STANLEY logo
MORGAN STANLEY
2.3M4.5%
Morgan Stanley logo
Morgan Stanley
· also on 13F· joint filing· may incl. warrants· filed Sep 2026
2.2M4.4%
VANGUARD CAPITAL MANAGEMENT LLC logo
VANGUARD CAPITAL MANAGEMENT LLC
2.2M4.2%
Millennium Management LLC logo
Millennium Management LLC
· also on 13F· joint filing· may incl. warrants· filed Jul 2026
1.7M3.4%
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
1.7M3.4%
FRED ALGER MANAGEMENT, LLC logo
FRED ALGER MANAGEMENT, LLC
1.5M3.1%
GEODE CAPITAL MANAGEMENT, LLC logo
GEODE CAPITAL MANAGEMENT, LLC
1.3M2.6%
MAK CAPITAL ONE LLC logo
MAK CAPITAL ONE LLC
1.3M2.5%
Sources: 13F, Form 4, 13D/13GO/S: 50.6M · as of 31 Jul 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$7.61$18.73
$17.98(93rd percentile)
Volume
Average Daily Volume795.12K
529.51K today vs 795.12K avg(-33%)

30d Avg

795.12K

60d Avg

671.23K

90d Avg

631.06K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...